These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 7700578)
21. Polymorphisms of the apolipoprotein E gene regulatory region and of the LDL receptor gene in late-onset Alzheimer's disease in relation to the plasma lipidic pattern. Scacchi R; Gambina G; Martini MC; Ruggeri M; Ferrari G; Silvestri M; Schiavon R; Corbo RM Dement Geriatr Cogn Disord; 2001; 12(2):63-8. PubMed ID: 11173876 [TBL] [Abstract][Full Text] [Related]
22. Receptor-mediated endocytosis of immunoglobulin-coated colloidal gold particles in cultured mouse peritoneal macrophages. Chloroquine and monensin inhibit transfer of the ligand from endocytic vesicles to lysosomes. Hedin U; Thyberg J Eur J Cell Biol; 1985 Nov; 39(1):130-5. PubMed ID: 2935397 [TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease. Marais AD Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326 [TBL] [Abstract][Full Text] [Related]
24. Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein. Cole GM; Ard MD Microsc Res Tech; 2000 Aug; 50(4):316-24. PubMed ID: 10936886 [TBL] [Abstract][Full Text] [Related]
25. Effects of an Aβ-antibody fragment on Aβ aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides. Montoliu-Gaya L; Mulder SD; Veerhuis R; Villegas S PLoS One; 2017; 12(11):e0188191. PubMed ID: 29155887 [TBL] [Abstract][Full Text] [Related]
26. Early-glycation of apolipoprotein E: effect on its binding to LDL receptor, scavenger receptor A and heparan sulfates. Laffont I; Shuvaev VV; Briand O; Lestavel S; Barbier A; Taniguchi N; Fruchart JC; Clavey V; Siest G Biochim Biophys Acta; 2002 Jun; 1583(1):99-107. PubMed ID: 12069854 [TBL] [Abstract][Full Text] [Related]
27. Role of microtubules in low density lipoprotein processing by cultured cells. Ostlund RE; Pfleger B; Schonfeld G J Clin Invest; 1979 Jan; 63(1):75-84. PubMed ID: 216709 [TBL] [Abstract][Full Text] [Related]
28. The Alzheimer's disease risk factors apolipoprotein E and TREM2 are linked in a receptor signaling pathway. Jendresen C; Årskog V; Daws MR; Nilsson LN J Neuroinflammation; 2017 Mar; 14(1):59. PubMed ID: 28320424 [TBL] [Abstract][Full Text] [Related]
29. Low-density-lipoprotein receptors in human fibroblasts are not degraded in lysosomes. Casciola LA; Grant KI; Gevers W; Coetzee GA; van der Westhuyzen DR Biochem J; 1989 Sep; 262(2):681-3. PubMed ID: 2803276 [TBL] [Abstract][Full Text] [Related]
30. LR11, an LDL receptor gene family member, is a novel regulator of smooth muscle cell migration. Zhu Y; Bujo H; Yamazaki H; Ohwaki K; Jiang M; Hirayama S; Kanaki T; Shibasaki M; Takahashi K; Schneider WJ; Saito Y Circ Res; 2004 Apr; 94(6):752-8. PubMed ID: 14764453 [TBL] [Abstract][Full Text] [Related]
31. A role for LRP4 in neuronal cell viability is related to apoE-binding. Lu Y; Tian QB; Endo S; Suzuki T Brain Res; 2007 Oct; 1177():19-28. PubMed ID: 17889837 [TBL] [Abstract][Full Text] [Related]
32. ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease. Lane-Donovan C; Herz J Trends Endocrinol Metab; 2017 Apr; 28(4):273-284. PubMed ID: 28057414 [TBL] [Abstract][Full Text] [Related]
33. Cellular catabolism of lipid poor apolipoprotein E via cell surface LDL receptor-related protein. Narita M; Holtzman DM; Fagan AM; LaDu MJ; Yu L; Han X; Gross RW; Bu G; Schwartz AL J Biochem; 2002 Nov; 132(5):743-9. PubMed ID: 12417024 [TBL] [Abstract][Full Text] [Related]
34. Regulation of ApoE receptor proteolysis by ligand binding. Hoe HS; Rebeck GW Brain Res Mol Brain Res; 2005 Jun; 137(1-2):31-9. PubMed ID: 15950758 [TBL] [Abstract][Full Text] [Related]
35. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Nathan BP; Bellosta S; Sanan DA; Weisgraber KH; Mahley RW; Pitas RE Science; 1994 May; 264(5160):850-2. PubMed ID: 8171342 [TBL] [Abstract][Full Text] [Related]
36. The role of apolipoprotein E in neurodegeneration and cardiovascular disease. Lopez MF; Krastins B; Ning M Expert Rev Proteomics; 2014 Jun; 11(3):371-81. PubMed ID: 24754513 [TBL] [Abstract][Full Text] [Related]
37. Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease. Christie RH; Chung H; Rebeck GW; Strickland D; Hyman BT J Neuropathol Exp Neurol; 1996 Apr; 55(4):491-8. PubMed ID: 8786409 [TBL] [Abstract][Full Text] [Related]
38. Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor. Knouff C; Briand O; Lestavel S; Clavey V; Altenburg M; Maeda N Biochim Biophys Acta; 2004 Aug; 1684(1-3):8-17. PubMed ID: 15450205 [TBL] [Abstract][Full Text] [Related]
39. Isoform-specific effect of apolipoprotein E on endocytosis of beta-amyloid in cultures of neuroblastoma cells. Yamauchi K; Tozuka M; Hidaka H; Nakabayashi T; Sugano M; Katsuyama T Ann Clin Lab Sci; 2002; 32(1):65-74. PubMed ID: 11848621 [TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein E, smooth muscle cells and the pathogenesis of cerebral amyloid angiopathy: the potential role of impaired cerebrovascular A beta clearance. Prior R; Wihl G; Urmoneit B Ann N Y Acad Sci; 2000 Apr; 903():180-6. PubMed ID: 10818506 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]